| Zacks Company Profile for Teladoc Health, Inc. (TDOC : NYSE) |
|
|
| |
| • Company Description |
| Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a week and 365 days a year. Its solutions are delivered with an approximate median response time of less than ten minutes in the United States for general medical inquiries from the time a member requests a general medical telehealth visit to the time they consult with a Teladoc Health network provider.
Number of Employees: 5,500 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $8.32 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 8,334,954 shares |
| Shares Outstanding: 175.43 (millions) |
| Market Capitalization: $1,459.62 (millions) |
| Beta: 1.84 |
| 52 Week High: $15.21 |
| 52 Week Low: $6.35 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
21.28% |
15.80% |
| 12 Week |
21.82% |
2.80% |
| Year To Date |
-8.47% |
-14.00% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Charles Divita - Chief Executive Officer and Director
David B. Snow - Chairman
Mala Murthy - Chief Financial Officer
Joseph Catapano - Chief Accounting Officer
J. Eric Evans - Director
|
|
Peer Information
Teladoc Health, Inc. (CHCR)
Teladoc Health, Inc. (ESRX)
Teladoc Health, Inc. (MYDP)
Teladoc Health, Inc. (COR)
Teladoc Health, Inc. (GBCS)
Teladoc Health, Inc. (LAXAF)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 87918A105
SIC: 8011
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/30/25
|
|
Share - Related Items
Shares Outstanding: 175.43
Most Recent Split Date: (:1)
Beta: 1.84
Market Capitalization: $1,459.62 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $-0.21 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $-0.90 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 9.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: 55.70% |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 07/30/25 |
|
|
|
| |
